Medtronic announces two-year trial outcomes of Evolut TAVR

In the Know: Healthcare News for March 10, 2025 - Medical Alley

Medtronic has positive TAVR results in small aortic annulus patients Boston Scientific leads $175M investment in 4C Medical Lilly’s baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study Mayo Clinic’s $1.3B operating profit sets new yearly record Vail Scientific Taps Minnetronix to Redesign Device for Earlier, Faster Sepsis Screening FDA Accepts Supplemental Biologics Lic…

CRT 2025: Improved haemodynamics seen with supra-annular TAVI system at two years in SMART trial - Cardiovascular News

Howard Herrmann presents two-year SMART trial data at CRT 2025 Two-year results of the SMART trial, comparing two commonly used transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic stenosis in patients with small aortic annuli, have shown that though the use of a supra-annular valve demonstrated an improvement on haemodynamic performance measures compared to a self-expanding platform, rates of mortality, disabling s…

Medtronic announces two-year trial outcomes of Evolut TAVR

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.The post Medtronic announces two-year trial outcomes of Evolut TAVR appeared first on Medical Device Network.